Literature DB >> 12531455

Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome.

Jacopo Vecchiet1, Francesco Cipollone, Katia Falasca, Andrea Mezzetti, Eligio Pizzigallo, Tonino Bucciarelli, Silvana De Laurentis, Giannapia Affaitati, Domenico De Cesare, Maria Adele Giamberardino.   

Abstract

In 21 patients with chronic fatigue syndrome (CFS) versus 20 normal subjects, we investigated the oxidant/antioxidant balance and its correlation with muscle symptoms. Patients versus controls showed significantly: lower Lag Phase and Vitamin E (Vit E) concentrations in plasma and low-density lipoproteins (LDL), higher LDL thiobarbituric acid reactive substances (TBARS), higher fatigue and lower muscle pain thresholds to electrical stimulation. A significant direct linear correlation was found between fatigue and TBARS, thresholds and Lag Phase, thresholds and Vit E in plasma and LDL. A significant inverse linear correlation was found between fatigue and Lag Phase, fatigue and Vit E, thresholds and TBARS. Increased oxidative stress and decreased antioxidant defenses are related to the extent of symptomatology in CFS, suggesting that antioxidant supplementation might relieve muscle symptoms in the syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531455     DOI: 10.1016/s0304-3940(02)01058-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  48 in total

Review 1.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

2.  High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome.

Authors:  Thozhukat Sathyapalan; Stephen Beckett; Alan S Rigby; Duane D Mellor; Stephen L Atkin
Journal:  Nutr J       Date:  2010-11-22       Impact factor: 3.271

Review 3.  Fibromyalgia and nutrition, what do we know?

Authors:  Laura-Isabel Arranz; Miguel-Angel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

4.  Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome.

Authors:  Kunihisa Miwa; Masatoshi Fujita
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 5.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

6.  Alterations in redox homeostasis in the elite endurance athlete.

Authors:  Nathan A Lewis; Glyn Howatson; Katie Morton; Jessica Hill; Charles R Pedlar
Journal:  Sports Med       Date:  2015-03       Impact factor: 11.136

7.  Effects of 12-week combined exercise therapy on oxidative stress in female fibromyalgia patients.

Authors:  Banu Sarıfakıoğlu; Aliye Yıldırım Güzelant; Eda Celik Güzel; Savaş Güzel; Ali Rıza Kızıler
Journal:  Rheumatol Int       Date:  2014-03-09       Impact factor: 2.631

8.  A gene signature for post-infectious chronic fatigue syndrome.

Authors:  John W Gow; Suzanne Hagan; Pawel Herzyk; Celia Cannon; Peter O Behan; Abhijit Chaudhuri
Journal:  BMC Med Genomics       Date:  2009-06-25       Impact factor: 3.063

9.  Oxidative stress in fibromyalgia and its relationship to symptoms.

Authors:  Cecilia P Chung; Dina Titova; Annette Oeser; Margaret Randels; Ingrid Avalos; Ginger L Milne; Jason D Morrow; C Michael Stein
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

10.  Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease.

Authors:  Mario D Cordero; Manuel De Miguel; Ana M Moreno Fernández; Inés M Carmona López; Juan Garrido Maraver; David Cotán; Lourdes Gómez Izquierdo; Pablo Bonal; Francisco Campa; Pedro Bullon; Plácido Navas; José A Sánchez Alcázar
Journal:  Arthritis Res Ther       Date:  2010-01-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.